How to Buy Bio Rad Laboratories Stock
Bio Rad Laboratories Inc
Bio Rad Laboratories is a medical device company located in California, United States, which is part of the Healthcare sector, and is traded under the ticker BIO on the NYSE exchange.
Bio Rad Laboratories stock last closed at $288.37, up 1.31% from the previous day, and has decreased 11.63% in one year. It has overperformed other stocks in the Medical Devices industry by 0.2 percentage points. Bio Rad Laboratories stock is currently +36.39% from its 52-week low of $211.43, and -25.68% from its 52-week high of $387.99.
There are currently 27.06M BIO shares outstanding. The market value of BIO is $7.80B. In the past 24 hours, 199,000 BIO shares were traded.
How to Buy Bio Rad Laboratories Stock
Not sure how to invest in Bio Rad Laboratories stock? Here's how.
- Choose where to buy Bio Rad Laboratories stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you determine where to buy Bio Rad Laboratories stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Fund your brokerage account: Select your method of payment and add your info.
- Research Bio Rad Laboratories stock: The Bio Rad Laboratories ticker symbol is BIO. Is Bio Rad Laboratories stock a good investment? Should you buy shares of BIO? How do BIO's underlying business fundamentals look? Do top analysts think Bio Rad Laboratories is a good buy? Why has BIO's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if BIO is a good stock to buy).
- Execute your BIO buy order: Decide if you will purchase BIO shares at the current market price or use a limit order to buy BIO shares at a given price.
- Get the latest scoop on your BIO position: Create a watchlist to track your investment in Bio Rad Laboratories shares.
Step 1: Choose where to buy Bio Rad Laboratories stock
You will need a brokerage account in order to access the NYSE market and buy BIO shares.
Our favorite brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked your brokerage, it's time to fill out some personal details so you can invest in BIO stock today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to start a new trading account.
- Send your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you've created your account on one of the best stock apps, you can securely and quickly fund your account:
Watch the tutorial below to see the process of depositing money into your investment account.
Step 4: Research Bio Rad Laboratories stock
After you have identified the best place to buy Bio Rad Laboratories stock, it's important to analyze their stock before you invest, so you actually understand the risk and upside.
Overview of key BIO info
BIO Overview
WallStreetZen was built to help part-time investors do more in-depth fundamental analysis.
You can view all of the due diligence checks on BIO's stock page.
How is BIO stock valued?
Analysts use many financial metrics, analyses, models, and charts to gauge BIO's true value.
Using relative valuations metrics:
- BIO may be undervalued based on its P/E ratio of 24.31x, relative to Medical Devices industry P/E ratio of 32.01x
- BIO may be undervalued based on its P/B ratio of 1.09x, relative to Medical Devices industry P/B ratio of 4.01x
You can do additional valuation research on BIO's stock here.
A quick look at BIO Financials
Positive Financial Indicators:
- There are more short-term assets than short-term liabilities on the BIO balance sheet.
- BIO profit margin has gone up from -51.7% to 12.5% in the past year.
- BIO earnings of $499.06M is not sufficient to cover its interest payments.
- BIO's operating cash flow of $534.16M allows it to safely service it's debt of $1.41B.
- There are more short-term assets than long-term liabilities on the BIO balance sheet.
Negative Financial Indicators:
- BIO has a relatively high debt to equity ratio of 0.43.
- Total BIO debt is higher than 5 years ago, relative to shareholder equity.
Is BIO stock a Buy, Hold, or Sell, according to analysts?
Out of 4 Wall Street analysts who research BIO, the consensus analyst rating on Bio Rad Laboratories is a Strong Buy
It's important to keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Bio Rad Laboratories stock forecast page.
BIO Momentum
BIO Growth Numbers
Last year, BIO earnings were $319.17M. During the last 5 year, BIO's earnings have gone up by -28.93% per year. This was slower than the Medical Devices industry average of 29.89%.
Last year, BIO revenue was $2.55B. Over the past five year, BIO's revenue has gone up by 2.18% per year. This was slower than the Medical Devices industry average of 10.46%.
You can analyze BIO's earnings and revenue performance here.
What are BIO insiders up to?
In the last year, insiders at BIO have sold more shares than they have bought.
Eva Anette Engelhardt, EVP President CDG of BIO, was the latest BIO insider to sell. They sold $23,248.72 worth of BIO stock on Jul 25, 2025.
Get more info about who owns BIO shares here.
Can I rely on BIO as an income stream?
No, Bio Rad Laboratories doesn't provide an income stream by paying out dividends.
What others are saying about BIO
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Execute your BIO buy order
You have two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually the best for newer investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a particular dollar amount, place a limit order.
Click the Open Trade button and eToro will place the order.
If you require additional info about investing in stocks on eToro, watch the how to video below:
Step 6: Get the latest scoop on your BIO position
Now that you own some BIO shares, you'll want to stay up-to-date on your new company.
Start a watchlist to see the latest developments about your BIO stock.
BIO Feed
How to Buy Stock in Bio Rad Laboratories
To reiterate, here are the 6 steps for buying Bio Rad Laboratories stock:
- Choose where to buy Bio Rad Laboratories stock
- Sign up for your brokerage account
- Fund your brokerage account
- Research Bio Rad Laboratories stock
- Execute your BIO buy order
- Get the latest scoop on your BIO position
If you are looking for a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you want to keep an eye on your new investment in Bio Rad Laboratories, click below.
More Stock Buying Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.